BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20351270)

  • 21. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells.
    Bai L; Wei L; Wang J; Li X; He P
    Int J Gynecol Cancer; 2006; 16(2):718-29. PubMed ID: 16681752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy.
    Franch HA; Shay JW; Alpern RJ; Preisig PA
    J Cell Biol; 1995 Apr; 129(1):245-54. PubMed ID: 7698989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
    Zhu D; Ye M; Zhang W
    Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional regulation of the EGF receptor promoter by HPV16 and retinoic acid in human ectocervical epithelial cells.
    Sizemore N; Choo CK; Eckert RL; Rorke EA
    Exp Cell Res; 1998 Oct; 244(1):349-56. PubMed ID: 9770378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
    Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
    Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA.
    Yoshinouchi M; Yamada T; Kizaki M; Fen J; Koseki T; Ikeda Y; Nishihara T; Yamato K
    Mol Ther; 2003 Nov; 8(5):762-8. PubMed ID: 14599809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
    Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
    Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV-18 E6 Oncoprotein and Its Spliced Isoform E6*I Regulate the Wnt/β-Catenin Cell Signaling Pathway through the TCF-4 Transcriptional Factor.
    Muñoz-Bello JO; Olmedo-Nieva L; Castro-Muñoz LJ; Manzo-Merino J; Contreras-Paredes A; González-Espinosa C; López-Saavedra A; Lizano M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.
    Morel A; Baguet A; Perrard J; Demeret C; Jacquin E; Guenat D; Mougin C; Prétet JL
    Oncotarget; 2017 Jul; 8(28):46163-46176. PubMed ID: 28521287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of HPV integration, viral gene expression and E6E7 alternative transcripts by RNA-Seq: A descriptive study in invasive cervical cancer.
    Brant AC; Menezes AN; Felix SP; de Almeida LM; Sammeth M; Moreira MAM
    Genomics; 2019 Dec; 111(6):1853-1861. PubMed ID: 30552977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
    Harden ME; Prasad N; Griffiths A; Munger K
    mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
    Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
    Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.
    Liu X; Dakic A; Chen R; Disbrow GL; Zhang Y; Dai Y; Schlegel R
    J Virol; 2008 Dec; 82(23):11568-76. PubMed ID: 18818322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways.
    Smeets SJ; van der Plas M; Schaaij-Visser TB; van Veen EA; van Meerloo J; Braakhuis BJ; Steenbergen RD; Brakenhoff RH
    Int J Cancer; 2011 Apr; 128(7):1596-605. PubMed ID: 20499310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.